The use of sirolimus combined with tacrolimus and low-dose methotrexate is effective in preventing graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.

被引：2
|
作者：
Nakamura, Ryotaro
Rodriguez, Roberto
Nademanee, Auayporn
Palmer, Joycelynne
Senitzer, David
Snyder, David
Zain, Jasmine
Pullarkat, Vinod
Forman, Stephen J.
Parker, Pablo Miguel
机构：
[1] City Hope Comprehens Canc Ctr, Div Hematol HCT, Duarte, CA USA
[2] City Hope Comprehens Canc Ctr, Dept Biostat, Duarte, CA USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2866.2866
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2866
引用
收藏
页码：811A / 811A
页数：1
相关论文
共 50 条
  • [1] THE USE OFSIROLIMUS COMBINED WITH TACROLIMUS AND LOW-DOSE METHOTREXATE TO PREVENT GRAFT-VERSUS-HOST DISEASE FOLLOWING UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Nakamura, R.
    Rodriguez, R.
    Palmer, J.
    Nademanee, A.
    Sun, J.
    Senitzer, D.
    Pullarkat, V
    Aljitawi, O.
    Zain, J.
    Snyder, D.
    Parker, P. M.
    Forman, S. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 105 - 105
  • [2] Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
    Antin, JH
    Kim, HT
    Cutler, C
    Ho, VT
    Lee, SJ
    Miklos, DB
    Hochberg, EP
    Wu, CJ
    Alyea, EP
    Soiffer, RJ
    BLOOD, 2003, 102 (05) : 1601 - 1605
  • [3] Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    X-J Huang
    Q Jiang
    H Chen
    L Xu
    D Liu
    Y Chen
    W Han
    Y Zhang
    K Liu
    D Lu
    Bone Marrow Transplantation, 2005, 36 : 343 - 348
  • [4] Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Huang, XJ
    Jiang, Q
    Chen, H
    Xu, L
    Liu, D
    Chen, Y
    Han, W
    Zhang, Y
    Liu, K
    Lu, D
    BONE MARROW TRANSPLANTATION, 2005, 36 (04) : 343 - 348
  • [5] Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation
    Alyea, Edwin P.
    Li, Shuli
    Kim, Haesook T.
    Cutler, Corey
    Ho, Vincent
    Soiffer, Robert J.
    Antin, Joseph H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (08) : 920 - 926
  • [6] Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation
    Mattsson, J.
    Svenberg, P.
    Gustafsson, B.
    Remberger, M.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S234 - S234
  • [7] Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant
    Ceberio, Izaskun
    Devlin, Sean M.
    Sauter, Craig
    Barker, Juliet N.
    Castro-Malaspina, Hugo
    Giralt, Sergio
    Ponce, Doris M.
    Lechner, Lauren
    Maloy, Molly A.
    Goldberg, Jenna D.
    Perales, Miguel-Angel
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 663 - 670
  • [8] Randomized Trial of Tacrolimus and Methotrexate Versus Tacrolimus, Reduced Dose Methotrexate, and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease after Myeloablative Related and Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
    Hamilton, Betty K.
    Rybicki, Lisa A.
    Lucas, Taylor
    Corrigan, Donna
    Kalaycio, Matt
    Hanna, Rabi
    Rotz, Seth J.
    Dean, Robert M.
    Gerds, Aaron T.
    Hill, Brian T.
    Jagadeesh, Deepa
    Pohlman, Brad
    Copelan, Edward A.
    Majhail, Navneet S.
    BLOOD, 2021, 138
  • [9] SIROLIMUS IN COMBINATION WITH CYCLOSPORINE OR TACROLIMUS PLUS METHOTREXATE FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS AFTER HEMATOPOIETIC CELL TRANSPLANTATION FROM UNRELATED DONORS
    Furlong, T.
    H.-P, Kiem
    Appelbaum, F. R.
    Carpenter, P. A.
    Deeg, J.
    Doney, K.
    Flowers, M. E. D.
    Mielcarek, M.
    Nash, R. A.
    Storh, R.
    Martin, P. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 140 - 141
  • [10] Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
    Cutler, C
    Kim, HT
    Hochberg, E
    Ho, V
    Alyea, E
    Lee, SJ
    Fisher, DC
    Miklos, D
    Levin, J
    Sonis, S
    Soiffer, RJ
    Antin, JH
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (05) : 328 - 336
12345